Eurobio Scientific and Vivo Medical Group enter into exclusive negotiations for the acquisition of two companies in the United Kingdom

    NEXT STORY
    Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9th
    PREV STORY
    Altran expands European Data Science and AI capabilities
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Shire plc : New Data on the Cardiovascular Safety of Prucalopride Presented at 2018 Digestive Disease Week Annual Meeting

    New Data on the Cardiovascular Safety of Prucalopride Presented at 2018 Digestive Disease Week ...

    author_avatar
    NASDAQ Market News

    Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization

    author_avatar
    NASDAQ Market News

    Zai Lab Announces Upcoming Presentations at September Conferences

    author_avatar
    NASDAQ Market News